Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 307 for infectious diseases

Edit search filters
  1. Efficacy And Safety Of Maribavir In Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory Or Resistant To Treatment

    Rochester, MN

  2. Prophylaxis Versus Preemptive Therapy for the Prevention of CMV in Liver Transplant Recipients

    Rochester, MN

  3. Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papillomavirus-Related Cancer in Adult Women After Kidney Transplant

    Rochester, MN

  4. A Study to Better Understand the Immune Response to the Flu Vaccine (MF59) and the High Dose Flu Vaccine (HDFlu) in People 65 Years of Age and Older

    Rochester, MN

  5. A Study To Compare The Effectiveness And Safety Of ABT-493/ABT-530 To Sofosbuvir Given Together With Declatasvir In Adults With A Chronic Hepatitis C Virus Infection

    Scottsdale/Phoenix, AZ

  6. Safety and Efficacy of IMM 124-E for Patients with Severe Alcoholic Hepatitis

    Rochester, MN

  7. Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis

    Rochester, MN

  8. Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

    Scottsdale/Phoenix, AZ

  9. A Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Co-Administration Of ABT-493 And ABT-530 With And Without RBV In Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 Or 6 Infection

    Scottsdale/Phoenix, AZ

  10. A Study of Static versus Articulating Antibiotic Spacer for Periprosthetic Joint Infection in Total Knee Arthroplasty

    Rochester, MN

.

Mayo Clinic Footer